Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has a beta value of 0.91 and has seen 1.77 million shares traded in the last trading session. The company, currently valued at $3.80M, closed the last trade at $0.35 per share which meant it lost -$0.05 on the day or -11.75% during that session. The VRPX stock price is -1465.71% off its 52-week high price of $5.48 and 17.14% above the 52-week low of $0.29. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.69 million shares traded. The 3-month trading volume is 3.36 million shares.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Sporting -11.75% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VRPX stock price touched $0.35 or saw a rise of 27.08%. Year-to-date, Virpax Pharmaceuticals Inc shares have moved -88.97%, while the 5-day performance has seen it change 11.01%. Over the past 30 days, the shares of Virpax Pharmaceuticals Inc (NASDAQ:VRPX) have changed -45.24%. Short interest in the company has seen 0.35 million shares shorted with days to cover at 1.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 88.33% from current levels. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the current price level is -757.14% off the targeted high while a plunge would see the stock gain -757.14% from current levels.
Virpax Pharmaceuticals Inc (VRPX) estimates and forecasts
The company’s shares have lost -53.50% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -20.69% over the past 5 years.
VRPX Dividends
Virpax Pharmaceuticals Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Insiders own 3.72% of the company shares, while shares held by institutions stand at 1.90% with a share float percentage of 1.97%. Investors are also buoyed by the number of investors in a company, with Virpax Pharmaceuticals Inc having a total of 10.0 institutions that hold shares in the company. The top two institutional holders are PARALLEL ADVISORS, LLC with over 1.0 shares worth more than $1.0. As of 2024-06-30, PARALLEL ADVISORS, LLC held 0.0001% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund . As of Oct 31, 2024 , the former fund manager holds about 0.31% shares in the company for having 25.47 shares of worth $8992.0 while later fund manager owns 8.76 shares of worth $3090.0 as of Oct 31, 2024 , which makes it owner of about 0.11% of company’s outstanding stock.
